Key takeaway
Among 3067 US adults with hypertension, those with a neutrophil-to-lymphocyte ratio (NLR) above 3.5 had higher all-cause (HR 1.96) and cardiovascular mortality (HR 2.33) over a median 92.0 months. This is observational, and the ratio only modestly predicted survival (areas under the curve 0.64 to 0.70).
Study design
Research article
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Better markers of prognosis could help manage hypertension. The NLR, a blood count ratio that reflects inflammation, has been linked to cardiovascular outcomes. The authors tested whether NLR is associated with all-cause and cardiovascular death in people with hypertension, and whether kidney function (eGFR) helps explain it.
Who and how
Analysis of 3067 hypertensive adults from the National Health and Nutrition Examination Surveys (NHANES) 2009-2014, with deaths from the National Death Index. Restricted cubic splines showed the shape of the NLR-mortality link, weighted Cox models estimated independent associations (NLR above 3.5 versus 3.5 or below), time-dependent receiver operating characteristic curves assessed prediction, and mediation analysis tested the role of eGFR. The abstract does not list the covariates adjusted for.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Over a median follow-up of 92.0 months there were 538 deaths, including 114 cardiovascular deaths. Higher NLR was positively associated with both all-cause and cardiovascular mortality.
- 2The higher NLR group (above 3.5) had a higher risk of all-cause death (HR 1.96, 95% CI 1.52 to 2.52, p < 0.0001) and cardiovascular death (HR 2.33, 95% CI 1.54 to 3.51, p < 0.0001).
- 3eGFR partly mediated the link, by 5.4% for all-cause and 4.7% for cardiovascular mortality.
- 4For all-cause mortality, the area under the curve at 3, 5 and 10 years was 0.68, 0.65 and 0.64; for cardiovascular mortality it was 0.68, 0.70 and 0.69.
Limits & uncertainty
- 1Observational data: illness, infection or other conditions can raise NLR and death risk at the same time, so NLR may be a marker rather than a cause.
- 2NLR was measured once at baseline, whereas blood counts vary from day to day.
- 3Only 114 cardiovascular deaths occurred, and the prediction values of 0.64 to 0.70 are modest, so NLR alone is not an accurate predictor for an individual.
- 4The claim that elevated NLR independently confers risk goes further than this design allows; this reading is based on the abstract only.
What to take from it
NLR is a routine blood test result that doctors can see on a standard blood count, and a high value may flag people who deserve closer attention. It cannot diagnose anything or tell an individual their outlook, so discuss any abnormal result with your clinician.
Reading your own data
NLR comes from a lab blood count, not a wearable. Related signals you can follow yourself are home blood pressure, resting heart rate and sleep, but these do not measure inflammation directly, and changes should be compared on the same device and conditions.
How to read this evidence
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Identifying reliable prognostic markers is crucial for the effective management of hypertension. The neutrophil-to-lymphocyte ratio (NLR) has emerged as a potential inflammatory marker linked to cardiovascular outcomes. This study aims to investigate the association of NLR with all-cause and cardiovascular mortality among patients with hypertension.
Methods
This study analyzed data from 3067 hypertensive adults in the National Health and Nutritional Examination Surveys (NHANES) from 2009 to 2014. Mortality details were obtained from the National Death Index (NDI). Restricted cubic spline (RCS) was deployed to visualize the association of the NLR with mortality risk. Weighted Cox proportional hazards models were employed to assess the independent association of NLR with mortality risk. Time-dependent receiver operating characteristic curve (ROC) analysis was conducted to access the predictive ability of NLR for survival. Mediation analysis was used to explore the indirect impact of NLR on mortality mediated through eGFR.
Results
Over a median 92.0-months follow-up, 538 deaths occurred, including 114 cardiovascular deaths. RCS analysis revealed a positive association between NLR and both all-cause and cardiovascular mortality. Participants were stratified into higher (> 3.5) and lower (≤ 3.5) NLR groups. Weighted Cox proportional hazards models demonstrated that individuals with higher NLR had a significantly increased risk of all-cause (HR 1.96, 95% confidence interval (CI) 1.52-2.52, p < 0.0001) and cardiovascular mortality (HR 2.33, 95% CI 1.54-3.51, p < 0.0001). Stratified and interaction analysis confirmed the stability of the core results. Notably, eGFR partially mediated the association between NLR and both all-cause and cardiovascular mortality by a 5.4% and 4.7% proportion, respectively. Additionally, the areas under the curve (AUC) of the 3-, 5- and 10- year survival was 0.68, 0.65 and 0.64 for all-cause mortality and 0.68, 0.70 and 0.69 for cardiovascular mortality, respectively.
Conclusion
Elevated NLR independently confers an increased risk for both all-cause and cardiovascular mortality in individuals with hypertension.
Sources & attribution
The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension.
Zhang X, Wei R, Wang X, Zhang W, Li M, Ni T, Weng W, Li Q.
Cardiovascular diabetology · 2024-04-02
DOI: 10.1186/s12933-024-02191-5 ↗PubMed · 38566082 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

